MedPath

Research on efficacy of Shengmai Yin in the treatment of normal tension glaucoma

Not Applicable
Conditions
ormal Tension Glaucoam
Registration Number
ITMCTR2000002930
Lead Sponsor
Beijing Tongren Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Diagnosis of normal tension glaucoma, adhere to drugs to reduce intraocular pressure treatment.
2. Aged 18-60 years old;
3. Informed willing to participate in the research project, and signed the informed consent;
4. Have the ability to walk independently or subsequent visit, correct visual acuity >=0.7, ensure accurate visual field examination.

Exclusion Criteria

1. The diagnosis was NTG, but the age was not within 18-60 years old.
2. Severe systemic disease or cardiopulmonary dysfunction was found after inclusion, and no tuberculosis or malignant tumor was found, which required medical treatment to keep the whole body healthy.
3. After enrollment, patients may apply for withdrawal from the study for any reason.
4. After enrollment, because the intervention methods adopted in the study could not effectively prevent the progression of NTG. In the first 6 months, visual field defects with MD exceeding -5.0dB or above appeared in either eye, or surgical intervention was required.

Study & Design

Study Type
Observational study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Visual Field Index, Optic Nerve Blood Flow, Blood Pressure;
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath